Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Other disposition Director disposed of 10,667 shares (other)
  2. 4 Grant or award Director acquired 8,000 shares (grant or award)
  3. 4 Grant or award Director acquired 8,000 shares (grant or award)
  4. 4 Grant or award Director acquired 8,000 shares (grant or award)
  5. 4 Planned sale Director sold 3,200 shares at $5.05 ($16,149)
  6. 4 Grant or award Director acquired 8,000 shares (grant or award)
  7. 4 Grant or award Director acquired 8,000 shares (grant or award)
  8. 4 Grant or award Director acquired 8,000 shares (grant or award)
  9. 4 Grant or award Director acquired 8,000 shares (grant or award)
  10. 4 Planned sale Chief Executive Officer sold 79,712 shares at $5.95 ($474,239)
  11. 4 Planned sale EVP and General Counsel sold 7,373 shares at $9.14 ($67,402)
  12. 4 Planned sale Director sold 10,056 shares at $9.45 ($95,063)
  13. 4 Planned sale EVP & Chief Technology Officer sold 14,168 shares at $9.45 ($133,936)
  14. 4 Grant or award EVP & Chief Financial Officer acquired 40,000 shares (grant or award)
  15. 4 Grant or award EVP and Chief Medical Officer acquired 40,000 shares (grant or award)
  16. 4 Planned sale SVP, Chief Accounting Officer sold 1,562 shares at $9.45 ($14,766)
  17. 4 Planned sale Chief Executive Officer sold 16,122 shares at $9.45 ($152,408)
  18. 4 Planned sale EVP and General Counsel sold 5,140 shares at $9.45 ($48,590)
  19. 4 Planned sale Director sold 10,964 shares at $9.81 ($107,575)
  20. 4 Planned sale SVP, Chief Accounting Officer sold 1,562 shares at $9.15 ($14,291)

Page 4 of 25 · 491 filings